SCHEMBL29757745

SCHEMBL29757745

CP(C)(=O)c1c(Nc2nc(Cl)ncc2Cl)ccc2nccnc12

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 17/20 0.49
▸ INSR P06213 2/20 0.39
▸ IGF1R P08069 2/20 0.39
▸ ALK Q9UM73 2/20 0.39
▸ CDK7 P50613 1/20 0.36
▸ CDK9 P50750 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22025609 1.00 EGFR (0.49) EGFRINSRIGF1RALKCDK7
SCHEMBL22026203 0.89 EGFR (0.45) EGFR
SCHEMBL30748540 0.89 EGFR (0.45) EGFR
SCHEMBL22595311 0.89 EGFR (0.51) EGFRINSRIGF1RALKCDK9
SCHEMBL22025651 0.88 EGFR (0.49) EGFR
SCHEMBL29747109 0.88 EGFR (0.49) EGFR
SCHEMBL30018877 0.88 EGFR (0.40) EGFRINSRIGF1RALKCDK9
SCHEMBL22595435 0.88 EGFR (0.40) EGFRINSRIGF1RALKCDK9
SCHEMBL30018602 0.86 EGFR (0.49) EGFR
SCHEMBL28609013 0.86 EGFR (0.49) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116888108-B Novel EGFR degradation agent 上海齐鲁制药研究中心有限公司 2024-04-19 — — CN disclosed
CN-117425646-A Phosphono derivative, composition thereof and pharmaceutical application thereof 西藏海思科制药有限公司 2024-01-19 — — CN disclosed
CN-116888108-A Novel EGFR degradation agent 上海齐鲁制药研究中心有限公司 2023-10-13 — — CN disclosed
CN-113166103-B EGFR inhibitor and application thereof 江苏先声药业有限公司 2022-12-16 — — CN disclosed
CN-114728932-A Polyarylates as EGFR kinase inhibitors 江苏先声药业有限公司 2022-07-08 — — CN disclosed
Send feedback